相似文献
1
Pathology of gastric intestinal metaplasia: clinical implications.胃肠化生的病理学：临床意义
Am J Gastroenterol. 2010 Mar;105(3):493-8. doi: 10.1038/ajg.2009.728.
2
Spotlight: Gastric Intestinal Metaplasia.聚焦：胃黏膜肠化生
Gastroenterology. 2020 Feb;158(3):704. doi: 10.1053/j.gastro.2020.01.012.
3
Gastritis staging as a clinical priority.胃炎分期作为临床首要任务。
Eur J Gastroenterol Hepatol. 2018 Feb;30(2):125-129. doi: 10.1097/MEG.0000000000001015.
4
Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice.胃小肠化生的组织学亚型：概述及临床实践考量
Gastroenterology. 2020 Feb;158(3):745-750. doi: 10.1053/j.gastro.2019.12.004. Epub 2019 Dec 6.
5
AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes.美国胃肠病学会关于胃肠化生的技术审查——自然史与临床结局
Gastroenterology. 2020 Feb;158(3):705-731.e5. doi: 10.1053/j.gastro.2019.12.001. Epub 2019 Dec 6.
6
AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia.美国胃肠病学会关于胃肠化生管理的临床实践指南
Gastroenterology. 2020 Feb;158(3):693-702. doi: 10.1053/j.gastro.2019.12.003. Epub 2019 Dec 6.
7
How harmful is the presence of intestinal metaplasia in the stomach?胃内肠化生的存在有多大危害？
Gastroenterology. 2009 Apr;136(4):1461-2; author reply 1462. doi: 10.1053/j.gastro.2008.11.064. Epub 2009 Feb 24.
8
9
Gastric Intestinal Metaplasia (GIM): Clinical Decision Support Tool.胃肠化生（GIM）：临床决策支持工具。
Gastroenterology. 2020 Feb;158(3):703. doi: 10.1053/j.gastro.2020.01.011. Epub 2020 Jan 11.
10
Preinvasive neoplasia in the stomach: diagnosis and treatment.胃的癌前肿瘤：诊断与治疗
Clin Gastroenterol Hepatol. 2007 Sep;5(9):1018-23. doi: 10.1016/j.cgh.2007.07.004.
引用本文的文献
1
Age-Related Decline of Gastric Secretion: Facts and Controversies.胃分泌的年龄相关性下降：事实与争议
Biomedicines. 2025 Jun 25;13(7):1546. doi: 10.3390/biomedicines13071546.
2
Gastric Signet Ring Cell Carcinoma in a Helicobacter pylori-Positive 10-Year-Old Boy: A Case Report and Literature Review.一名幽门螺杆菌阳性的10岁男孩的胃印戒细胞癌：病例报告及文献综述
Cancer Sci. 2025 Aug;116(8):2064-2074. doi: 10.1111/cas.70112. Epub 2025 Jun 11.
3
Alterations in polyamine metabolism induced by the pathogen Helicobacter pylori: Implications for gastric inflammation and carcinogenesis.幽门螺杆菌病原体诱导的多胺代谢改变：对胃炎症和致癌作用的影响。
Methods Enzymol. 2025;715:137-153. doi: 10.1016/bs.mie.2025.01.037. Epub 2025 Feb 20.
4
Research progress on monocyte/macrophage in the development of gastric cancer.单核细胞/巨噬细胞在胃癌发生发展中的研究进展
Future Oncol. 2025 Jun;21(15):1939-1949. doi: 10.1080/14796694.2025.2504334. Epub 2025 May 12.
5
Effect of infection on immunotherapy for gastrointestinal cancer: a narrative review.感染对胃肠道癌免疫治疗的影响：一项叙述性综述
Immunotherapy. 2025 Apr;17(5):355-368. doi: 10.1080/1750743X.2025.2479410. Epub 2025 Mar 14.
6
Value of serum pepsinogen ratio screening for early gastric cancer and precancerous lesions in Youcheng area.血清胃蛋白酶原比值筛查在右城地区早期胃癌及癌前病变中的价值
World J Gastrointest Surg. 2024 Dec 27;16(12):3729-3736. doi: 10.4240/wjgs.v16.i12.3729.
7
FOLR2 macrophage depletion from intestinal metaplasia to early gastric cancer: single-cell sequencing insight into gastric cancer progression.从肠化生到早期胃癌的FOLR2巨噬细胞耗竭：单细胞测序洞察胃癌进展
J Exp Clin Cancer Res. 2024 Dec 19;43(1):326. doi: 10.1186/s13046-024-03245-y.
8
IL-17 signaling protects against induced gastric cancer.IL-17 信号转导对诱导性胃癌具有保护作用。
Gut Microbes. 2024 Jan-Dec;16(1):2430421. doi: 10.1080/19490976.2024.2430421. Epub 2024 Nov 26.
9
The role of cuproptosis in gastric cancer.铜死亡在胃癌中的作用。
Front Immunol. 2024 Oct 30;15:1435651. doi: 10.3389/fimmu.2024.1435651. eCollection 2024.
10
Multi-bioinformatics revealed potential biomarkers and repurposed drugs for gastric adenocarcinoma-related gastric intestinal metaplasia.多组学分析揭示胃腺癌相关肠上皮化生的潜在生物标志物和再利用药物。
NPJ Syst Biol Appl. 2024 Nov 4;10(1):127. doi: 10.1038/s41540-024-00455-0.
本文引用的文献
1
Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.早期根除幽门螺杆菌可降低消化性溃疡病患者患胃癌的风险。
Gastroenterology. 2009 Nov;137(5):1641-8.e1-2. doi: 10.1053/j.gastro.2009.07.060. Epub 2009 Aug 5.
2
Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?幽门螺杆菌根除与胃癌：马何时已出厩？
Am J Gastroenterol. 2009 Jun;104(6):1342-5. doi: 10.1038/ajg.2008.15.
3
The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice.利用临床、组织学和血清学参数预测肠化生的胃内范围：常规实践建议
Gastrointest Endosc. 2009 Jul;70(1):18-25. doi: 10.1016/j.gie.2008.08.041. Epub 2009 Feb 27.
4
Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.黏膜病变的年龄和严重程度会影响幽门螺杆菌相关胃十二指肠疾病中血清学标志物的表现。
Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2498-504. doi: 10.1158/1055-9965.EPI-08-0289.
5
Non-invasive tests in gastric diseases.胃部疾病的非侵入性检测
Dig Liver Dis. 2008 Jul;40(7):523-30. doi: 10.1016/j.dld.2008.02.028. Epub 2008 Apr 24.
6
OLGA staging for gastritis: a tutorial.用于胃炎的OLGA分期：教程
Dig Liver Dis. 2008 Aug;40(8):650-8. doi: 10.1016/j.dld.2008.02.030.
7
Biology of intestinal metaplasia in 2008: more than a simple phenotypic alteration.2008年肠化生的生物学：不仅仅是简单的表型改变。
Dig Liver Dis. 2008 Jul;40(7):510-22. doi: 10.1016/j.dld.2008.02.029. Epub 2008 Apr 9.
8
Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.根除幽门螺杆菌对胃黏膜肠化生组织学及细胞表型的影响
Clin Gastroenterol Hepatol. 2008 Apr;6(4):409-17. doi: 10.1016/j.cgh.2007.12.044. Epub 2008 Mar 5.
9
Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.哥斯达黎加血清胃蛋白酶原水平、幽门螺杆菌CagA状态及与胃前驱病变相关的细胞因子基因多态性
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2631-6. doi: 10.1158/1055-9965.EPI-07-0215.
10
Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia.形态学特征有助于鉴别巴雷特食管与伴有肠化生的贲门炎。
Am J Surg Pathol. 2007 Nov;31(11):1733-41. doi: 10.1097/PAS.0b013e318078ce91.
Zotero 插件